# OnCo record enliven-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/enliven-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "enliven-therapeutics" ;
  schema:name "Enliven Therapeutics"@en ;
  schema:description "Enliven Therapeutics designs cleaner versions of cancer pills that already work. Its lead drug targets the BCR-ABL protein in chronic myeloid leukaemia and a second drug targets mutated HER2 in lung cancer."@en ;
  schema:url <https://onco.cc/companies/enliven-therapeutics/>, <https://www.enliventherapeutics.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.enliventherapeutics.com/>, <https://www.enliventherapeutics.com/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1672619/000119312523056303/d464771dex991.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/her2/> .